$0.570000
-0.02-3.55%
At Close: -
$0.550000
-0.02-3.51%
After Hours: 6:33 PM EDT
15 minutes delayed
Galecto: Insider buying and selling updated today.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Aug 17, 2023 | ORBIMED ADVISORS LLCOrbiMed Genesis GP LLCOrbiMed Israel GP II LPOrbiMed Advisors Israel II LtdOrbiMed Capital GP VII LLC | 10% OWNER | -822.68K | $0.75 | -$617.01K | SELL | -35.26% | 1.51M | Aug 15 | View |
Aug 02, 2023 | ORBIMED ADVISORS LLCOrbiMed Genesis GP LLCOrbiMed Israel GP II LPOrbiMed Advisors Israel II LtdOrbiMed Capital GP VII LLC | 10% OWNER | -209.40K | $3.00 | -$628.20K | SELL | -9.04% | 2.11M | Jul 31 | View |
Jul 27, 2023 | ORBIMED ADVISORS LLCOrbiMed Genesis GP LLCOrbiMed Israel GP II LPOrbiMed Advisors Israel II LtdOrbiMed Capital GP VII LLC | 10% OWNER | -39.20K | $2.92 | -$114.46K | SELL | -1.71% | 2.26M | Jul 25 | View |
Jul 17, 2023 | ORBIMED ADVISORS LLCOrbiMed Genesis GP LLCOrbiMed Israel GP II LPOrbiMed Advisors Israel II LtdOrbiMed Capital GP VII LLC | 10% OWNER | -194.70K | $2.40 | -$467.28K | SELL | -7.85% | 2.29M | Jul 13 | View |
Apr 17, 2023 | ORBIMED ADVISORS LLCOrbiMed Genesis GP LLCOrbiMed Israel GP II LPOrbiMed Advisors Israel II LtdOrbiMed Capital GP VII LLC | 10% OWNER | -68.48K | $1.87 | -$128.26K | SELL | -2.75% | 2.42M | Apr 13 - Apr 17 | View |
Apr 12, 2023 | ORBIMED ADVISORS LLCOrbiMed Genesis GP LLCOrbiMed Israel GP II LPOrbiMed Advisors Israel II LtdOrbiMed Capital GP VII LLC | 10% OWNER | -67.54K | $1.80 | -$121.36K | SELL | -2.67% | 2.46M | Apr 10 - Apr 12 | View |
Apr 07, 2023 | ORBIMED ADVISORS LLCOrbiMed Genesis GP LLCOrbiMed Israel GP II LPOrbiMed Advisors Israel II LtdOrbiMed Capital GP VII LLC | 10% OWNER | -102.63K | $2.16 | -$221.99K | SELL | -3.93% | 2.51M | Apr 05 - Apr 06 | View |
Mar 23, 2022 | Bertil Lindmark | CHIEF MEDICAL OFFICER | 14.60K | $2.16 | $31.54K | BUY | 730.20% | 16.60K | Mar 22 | View |
Mar 23, 2022 | Hans Schambye | CHIEF EXECUTIVE OFFICER | 5.00K | $2.15 | $10.75K | BUY | 10.54% | 52.43K | Mar 22 | View |
Dec 06, 2021 | Garrett Winslow | GENERAL COUNSEL | 2.00K | $2.48 | $4.96K | BUY | 100.00% | 4.00K | Dec 03 | View |
Dec 06, 2021 | Jonathan Freve | CHIEF FINANCIAL OFFICER | 4.00K | $2.49 | $9.96K | BUY | 50.00% | 12.00K | Dec 03 | View |
Nov 10, 2021 | Hans Schambye | CHIEF EXECUTIVE OFFICER | 4.50K | $3.50 | $15.75K | BUY | 10.48% | 47.43K | Nov 09 | View |
Nov 09, 2021 | Jonathan Freve | CHIEF FINANCIAL OFFICER | 3.00K | $3.40 | $10.20K | BUY | 60.00% | 8.00K | Nov 08 | View |
Aug 19, 2021 | Jonathan Freve | CHIEF FINANCIAL OFFICER | 3.00K | $3.92 | $11.76K | BUY | 150.00% | 5.00K | Aug 18 | View |
Jun 28, 2021 | Bertil Lindmark | CHIEF MEDICAL OFFICER | 2.00K | $5.26 | $10.52K | BUY | ∞ | 2.00K | Jun 28 | View |
Jun 24, 2021 | Hans Schambye | CHIEF EXECUTIVE OFFICER | 3.00K | $5.11 | $15.33K | BUY | 7.51% | 42.93K | Jun 24 | View |
Jun 23, 2021 | Jonathan Freve | CHIEF FINANCIAL OFFICER | 2.00K | $4.74 | $9.48K | BUY | ∞ | 2.00K | Jun 23 | View |
Jun 23, 2021 | Garrett Winslow | GENERAL COUNSEL | 2.00K | $4.80 | $9.60K | BUY | ∞ | 2.00K | Jun 23 | View |
Nov 04, 2020 | ORBIMED ADVISORS LLCOrbiMed Advisors Israel II LtdOrbiMed Israel GP II LPOrbiMed Capital GP VII LLCOrbiMed Genesis GP LLC | — | 3.80M | $15.00 | $11.00M | DERIVATIVE CONVERSION | ∞ | 1.03M | Nov 02 | View |
Nov 04, 2020 | Quang Chau Khuong | — | 3.80M | $15.00 | $11.00M | DERIVATIVE CONVERSION | ∞ | 1.03M | Nov 02 | View |
Nov 04, 2020 | Stephan Christgau | — | 546.14K | $15.00 | $999.99K | DERIVATIVE CONVERSION | ∞ | 546.14K | Nov 02 | View |
Nov 04, 2020 | Peter Haahr Chief Financial Officer of Novo Holdings A/S | — | 2.50M | $15.00 | $5.00M | DERIVATIVE CONVERSION | ∞ | 2.50M | Nov 02 | View |
Browse insider trades on all stocks.